Related Experiment Video
Updated: Jul 19, 2026
08:07
Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
Published on: April 12, 2019
Osteosarcoma and osteoblastic differentiation: a new perspective on oncogenesis
Rex C Haydon1, Hue H Luu, Tong-Chuan He
1Department of Surgery, The University of Chicago Medical Center, Chicago, IL, USA. rhaydon@surgery.bsd.uchicago.edu
Clinical Orthopaedics and Related Research
|November 1, 2006
Summary
Osteosarcoma cells resist bone morphogenetic protein-induced differentiation due to blocked pathways. However, nuclear receptor agonists can successfully induce terminal differentiation, offering new therapeutic strategies for osteosarcoma treatment.
Area of Science:
- Oncology
- Cell Biology
- Molecular Biology
Background:
- Loss of cellular differentiation is a hallmark of osteosarcoma.
- Therapies aimed at restoring differentiation could be novel treatments for osteosarcoma.
Purpose of the Study:
- To investigate blocks in osteosarcoma differentiation pathways.
- To identify therapeutic strategies that can overcome these differentiation blocks.
Main Methods:
- Osteosarcoma cell lines were treated with bone morphogenetic proteins (BMPs).
- Expression profiling identified downstream BMP targets, including differentiation inhibitors and nuclear receptors.
- Nuclear receptor agonists (e.g., peroxisome proliferator-activated receptor gamma/retinoid X receptor agonists) were evaluated.
Main Results:
- BMP treatment in osteosarcoma cells led to increased tumor volume and failed osteoinduction.
- Expression analysis revealed upregulation of inhibitor of differentiation genes and peroxisome proliferator-activated receptor gamma.
- Peroxisome proliferator-activated receptor gamma/retinoid X receptor agonists induced terminal differentiation in all tested osteosarcoma cell lines, with synergistic effects when combined.
Conclusions:
- Osteosarcoma cells possess inherent blocks to BMP-induced differentiation.
- Nuclear receptor agonists can effectively bypass these blocks to induce terminal differentiation in osteosarcoma cells.
- This suggests a potential therapeutic avenue for osteosarcoma treatment.
Related Concept Videos
01:30Bone Cells and Tissue
Bones contain a relatively small number of cells entrenched in a matrix of organic and inorganic components. Although bone cells compose only a small amount of the bone volume, they are crucial to its function. Four types of cells are found within the bone tissue— osteoblasts, osteocytes, osteogenic cells, and osteoclasts.
Osteoblasts and Osteocytes
The osteoblast is the bone cell responsible for forming new bone tissue. It is found in the growing portions of bone, including the periosteum and...
Osteoblasts and Osteocytes
The osteoblast is the bone cell responsible for forming new bone tissue. It is found in the growing portions of bone, including the periosteum and...
01:31Osteoclasts in Bone Remodeling
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
01:24Bone Formation by Endochondral Ossification
Bone formation, or ossification, begins around the sixth to seventh week of embryonic development. Most bones develop from a cartilaginous template through the process of endochondral ossification. Cartilage formation begins when clusters of mesenchymal cells differentiate into chondrocytes. These chondrocytes proliferate rapidly and secrete an extracellular matrix that becomes encased in a membrane called the perichondrium. The resulting cartilage model provides a template that resembles the...
01:40Bone Remodeling
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.